The Rundown cover image

Trump Targets Netflix Amid DOJ Probe; Slaps New 15% Tariffs

The Rundown

00:00

Gilead Acquires Arcellx for Cell Therapy

Zaid explains Gilead's $7.8B buy of Arcellx and rationale around the Aneidocell multiple myeloma program.

Play episode from 07:40
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app